Madison Avenue Partners disclosed a new $142.51 million position in Indivior, representing 5.72% of its U.S. equity assets.
Madison Avenue Partners acquired 4,315,162 shares of Indivior (NASDAQ:INDV) in the first quarter, valued at $142.51 million based on average pricing. The stake was worth $131.53 million at quarter-end due to price movements and trading activity.
The new position accounted for 5.72% of the fund’s reportable U.S. equity assets as of March 31, 2026. Indivior shares have risen nearly 200% over the past year, significantly outperforming the S&P 500’s 28% gain. The fund’s top holdings include SNDK ($393.28 million) and GHC ($259.91 million).
Indivior, which specializes in opioid dependence treatments, closed at $36.02 on Friday, reflecting strong investor interest in its specialty pharmaceuticals business model.